Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MRPS18B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ANKRD52 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ZNF184 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | PYGO2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ANKRD34A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | NFATC1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TRIM13 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ARG1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SPINK2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TET3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |